Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated <i>KRAS</i> in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas.

Cancers (Basel) · 2023 · PMC10000455 · PMID 36900379

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the KRT81 high QM and DN group, there was a trend towards longer survival in patients with tumors with low levels of uPAR that did not reach statistical significance ( Figure 4 h,i and Supplementary Figure S4 ), indicating that the prognostic impact of uPAR may vary among different molecular subgroups. 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.